Reading Time: 5 minutesClinical trials determine if potential treatments are safe and aim to prove beyond reasonable doubt whether a drug is beneficial. They are therefore the gold
Search Results for: clinical trial
Reading Time: 4 minutesThe 25th International Symposium on ALS/MND began today in Brussels, Belgium. More than 900 delegates joined the opening session to hear Dr Alfred Sandrock from
Reading Time: 4 minutesThe top-line results from the Cytokinetics Inc Phase IIb clinical trial of Tirasemtiv were announced last week. Following this announcement, detailed results were then presented
Reading Time: 2 minutesA packed room at the 24th International Symposium on ALS/MND was given a fascinating whistle stop tour covering stem cells, robots and cellular garbage clearing,
Reading Time: 3 minutesA very much ‘must report on’ session of the 23rd International Symposium on ALS/MND was the clinical trials and trial design session. There are many
Reading Time: 3 minutesPromising results from a Phase II clinical trial for a drug called NP001 have been announced by the biopharmaceutical company Neuraltus. The trial, conducted in America, suggested
Reading Time: 2 minutesYesterday, we announced on our website the disappointing news that the UK-based lithium clinical trial showed that lithium carbonate is ineffective at treating MND. Commenting
Reading Time: 3 minutes“After a time where patients and sponsors of trials alike had become disheartened about the lack of positive clinical trials, it is exciting to see
Reading Time: < 1 minuteWe’re aware that thing’s may seem quiet in terms of ‘big’ MND research moments… almost too quiet… Well, today, the pharmaceutical companies Biogen Idec and Knopp Biosciences announced
Reading Time: 2 minutesThe remainder of the morning covered some of the preclinical research that has laid the foundations for current and forthcoming clinicalstudies. Prof Clive Svendsen, from University Wisconsin-Madison, gave an